Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured firm commitments for a $2.3 million institutional placement, ...

Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has entered a clinical research agreement with Vanderbilt Health in the US ...

Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 millionCompany accelerated payment ...

Company Outlook Q2 2026 Financial and Operational Overview: Rocket Doctor AI delivered sustained quarter-on-quarter financial performance in Q2 2026 relative to Q1 2026, building directly upon the ...

3 August 2026 – Faron approved the exercise of 3,657,321 special rights entitling to 3,657,321 shares in the Company, for an aggregate subscription price of EUR 1,578,499.74 in connection with the ...

Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in the Phase Ib FRIDA trial ...

The S&P/ASX Small Ordinaries (XSO) came under pressure on Thursday, falling 57.10 points, or 1.59%, to 3,524.20. The small-cap benchmark has now lost 47 points, or 1.32%, over the past five sessions, ...

The next era of air combat is already taking shape in classified design bays, digital simulation labs, and flight-test ...

How to Actually Operationalize a Bispecific Antibody Program / cancer, Jasmine Kamboj, Joanna Metzner-Sadurski, Jonathan ...

As Caring Place Healthcare Group faced a skilled nursing industry that was growing more and more technical and specific, they ...

To check your myelodysplastic syndrome (MDS) diagnosis and find out the subtype, your physician will do a complete physical exam and ask about your health history and any symptoms. You may also need ...